BIOTECHNOLOGY VALUE FUND
Biotechnology Value Fund is a San Francisco-based private investment partnership specializing in fundamentally-driven public biotechnology investments. Since its inception in 1993, BVF has strived to build concentrated, long-term investments in small-cap biotechnology companies while performing rigorous diligence and on-going monitoring of its investments. BVF is committed to working with its portfolio companies as partners in their successes.
BIOTECHNOLOGY VALUE FUND
Industry:
Biotechnology Venture Capital
Founded:
1993-01-01
Status:
Active
Contact:
(312)506-6479
Email Addresses:
[email protected]
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Apple Mobile Web Clips Icon WordPress PHP PHP 7 Twemoji OpenResty
Similar Organizations
Atlas Venture
Atlas Venture creates and invests in biotech startup companies with seed and early stage venture investments.
Azure Capital Partners
Azure Capital Partners is a venture capital firm specializing in early-stage and growth capital investments.
BioAdvance
BioAdvance is a Pennsylvania-based venture capital firm that provides funding to life sciences startups.
Current Employees Featured
Investments List
Date | Company | Article | Money raised |
---|---|---|---|
2022-08-19 | Kymera Therapeutics | Biotechnology Value Fund investment in Post-IPO Equity - Kymera Therapeutics | 150 M USD |
2021-07-13 | Nimbus Therapeutics | Biotechnology Value Fund investment in Venture Round - Nimbus Therapeutics | 105 M USD |
2021-04-08 | Ventus Therapeutics | Biotechnology Value Fund investment in Series B - Ventus Therapeutics | 100 M USD |
2021-03-30 | Pyxis Oncology | Biotechnology Value Fund investment in Series B - Pyxis Oncology | 152 M USD |
2020-12-28 | Gritstone Bio | Biotechnology Value Fund investment in Post-IPO Equity - Gritstone Bio | 125 M USD |
2020-07-22 | Olema Oncology | Biotechnology Value Fund investment in Series B - Olema Oncology | 54 M USD |
2020-06-11 | Autobahn Therapeutics | Biotechnology Value Fund investment in Series B - Autobahn Therapeutics | 76 M USD |
2020-05-20 | Surface Oncology | Biotechnology Value Fund investment in Post-IPO Equity - Surface Oncology | 28.9 M USD |
2020-03-12 | Kymera Therapeutics | Biotechnology Value Fund investment in Series C - Kymera Therapeutics | 102 M USD |
2020-01-31 | Syndax Pharmaceuticals | Biotechnology Value Fund investment in Post-IPO Debt - Syndax Pharmaceuticals | 30 M USD |
More informations about "Biotechnology Value Fund"
Biotechnology Value Fund - Investments, Portfolio & Company Exits
Biotechnology Value Fund has made 27 diversity investments. Their most recent diversity โฆSee details»
Hedge Fund - Biotechnology Value Fund / BVF Inc - Insider Monkey
Jul 24, 2017 Established in 1993, Biotechnology Value Fund is a private investment โฆSee details»
Biotechnology Value Fund Portfolio Companies - Crunchbase
Biotechnology Value Fund is an evergreen fund specializing in early stage financing. It focuses โฆSee details»
Biotechnology Value Fund (BVF Partners) - Golden
BVF Partners L.P. is a San Francisco-based private investment partnership specializing in โฆSee details»
Biotechnology Value Fund - Massinvestor Venture Capital and โฆ
Biotechnology Value Fund (BVF Partners) is a San Francisco-based private investment โฆSee details»
Biotechnology Value Fund LP - AUM 13F
Fund Details; Director: BVF I GP LLC, BVF Partners LP: Custodian: The Bank of New York โฆSee details»
Biotechnology Value Fund Investment Information | CipherBio
Find out which companies Biotechnology Value Fund is investing in, as well as the disease โฆSee details»
Mark Lampert - Lifeline Fund
Mark Lampert is the founder and president of the Biotechnology Value Fund, L.P., a San โฆSee details»
Small-Cap, Biotech-Focused Hedge Fund BVF's Top Q3 Picks
Dec 28, 2011 San Francisco-based Biotechnology Value Fund Partners (BVF), with $250 โฆSee details»
Biotechnology Value Fund L P Now Owns 9.60% of Protagonist
Fintel reports that Biotechnology Value Fund L P has filed a 13G form with the SEC disclosing โฆSee details»
Biotechnology Value Fund - Funding, Financials, Valuation
Biotechnology Value Fund has raised a single venture fund, Biotechnology Value Fund II. โฆSee details»
Institutional Top Ideas: Biotechnology Value Fund โฆ
Prior Entries in This Series#1: Baker Brothers#2: EcoR1 Capital#3: Deep Track Capital#4: โฆSee details»
Institutional Top Ideas Series: Biotechnology Value Fund
Jun 4, 2018 Possible 1 Sentence Thesis: Recently announced strategic plans appear to have โฆSee details»
7 Best Biotech ETFs to Buy Now | Investing | U.S. News
Jun 28, 2024 A great example is IBB, which tracks 215 holdings represented by the NYSE โฆSee details»
Backgrounder โ Government of Canada investments in COVID-19 โฆ
Feb 2, 2021 $600 million through the Strategic Innovation Fund to support COVID-19 vaccine โฆSee details»
Biotechnology Value Fund - Contacts, Employees, Board
Biotechnology Value Fund has 8 current employee profiles, including Portfolio Manager โฆSee details»
7 Best-Performing Biotech ETFs for November 2024 - NerdWallet
Nov 3, 2024 For example, shares of biopharmaceutical company Amgen Inc. make up (as of โฆSee details»
Whatโs ahead for biotech: Another wave or low tide? - McKinsey
Apr 30, 2021 The value of codevelopments, partnerships, joint ventures, licensing โฆSee details»
Fidelity Select Biotechnology Fund Stock Price - Morningstar
Sep 30, 2024 Fidelity Select Biotechnology Portfolio earns an Above Average Process Pillar โฆSee details»